R5 News
R5 expands its laboratories at BioCity
“The continued growth of our formulation business coupled with the diversity of the dosage for... Read More
VIP Visit to R5
Professor Danuta Hubner (Member of the European Commission, Commissioner for Regional Policy) visite... Read More
Export Award for R5
The award for Export Achievement was presented to R5 Pharmaceuticals at the prestigious Innovation D... Read More
MHRA audit success
A complete GMP audit of R5 was carried out this week (March 17 –19 2009) by two MHRA audi... Read More
R5 Pharmaceuticals Ltd.
R5 develops and manufactures new medicines and clinical trial materials for Phase 1 and Phase 2 clinical trials.
Our projects include most dosage forms and all are produced at R5's GMP labs.
R5 is licensed by MHRA for the manufacture and testing of Investigational Medical Products (IMPs) and Specials.
 |
 |
 |
 |
 |